CompanyGraph
The Sherwin-Williams Company
SHW · NYSE Arca · United States
sherwin-williams.comFinancials as of FY2025
What stands out
- Returns appear driven by leverage
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleMarket cap is $81.72B, higher than 95% of all stocks globally
- PositionGross margin is 49.1%, higher than 95% of its Specialty Chemicals peers (median 33%)
- Interpretations8 currently firing — 8
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.97%Above 5Y avg (0.87%)
Annual Rate
USD 3.20Paid quarterly
Payout Ratio
30.4%Sustainable
Consecutive Growth
19 yrStrong track record
Paying Dividends
26 yr
Last Ex-Dividend
May 22, 2026
Last Payment
Jun 5, 2026
The reported statements, read against the company's own industry.
What stands out
- Returns appear driven by leverage
Financials view
Market Capitalization
81.72BUSDvs all stocks (USD)
Trailing P/E
32.48xvs Specialty Chemicals peers
Revenue (TTM)
23.94BUSDvs all stocks (USD)
Profit Margin
10.86%vs Specialty Chemicals peers
Beta
1.10xvs all stocks
52-Week Change
-2.92%vs all stocks
Forward Annual Dividend Yield
0.97%vs all stocks
Market Capitalization
81.72BUSDvs all stocks (USD)
Enterprise Value
95.63BUSDvs all stocks (USD)
Trailing P/E
32.48xvs Specialty Chemicals peers
Forward P/E
24.89xvs Specialty Chemicals peers
PEG Ratio
4.10xvs Specialty Chemicals peers
Price to Sales (TTM)
3.41xvs Specialty Chemicals peers
Price to Book (MRQ)
18.33xvs Specialty Chemicals peers
Enterprise to Revenue
4.00xvs Specialty Chemicals peers
Enterprise to EBITDA
20.98xvs Specialty Chemicals peers
Gross Margin
49.07%vs Specialty Chemicals peers
Profit Margin
10.86%vs Specialty Chemicals peers
Operating Margin
14.16%vs Specialty Chemicals peers
Return on Assets (TTM)
9.45%vs Specialty Chemicals peers
Return on Equity (TTM)
60.72%vs Specialty Chemicals peers
Revenue (TTM)
23.94BUSDvs all stocks (USD)
Revenue per Share (TTM)
97.03USDUpdated Jul 19, 2026Quarterly Revenue Growth
6.80%vs Specialty Chemicals peers
Gross Profit (TTM)
11.74BUSDvs all stocks (USD)
EBITDA (TTM)
4.57BUSDvs all stocks (USD)
Net Income (TTM)
2.60BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.10%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
3.65BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
2.14BUSDvs all stocks (USD)
Forward Annual Dividend Rate
3.20USDUpdated Jul 19, 2026Forward Annual Dividend Yield
0.97%vs all stocks
Trailing Annual Dividend Rate
3.18USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.96%vs all stocks
5-Year Average Dividend Yield
0.87%vs all stocks
Payout Ratio
30.45%vs Specialty Chemicals peers
Revenue
23.57BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
12.06BUSDFY2025 · Dec 31, 2025Gross Profit
11.52BUSDFY2025 · Dec 31, 2025Operating Income
3.80BUSDvs all stocks (USD)
Pre-tax Income
3.34BUSDFY2025 · Dec 31, 2025Income Tax Expense
769.70MUSDFY2025 · Dec 31, 2025Net Income
2.57BUSDFY2025 · Dec 31, 2025EBIT
3.80BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
4.50BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
7.70BUSDFY2025 · Dec 31, 2025Other Operating Expenses
15.30MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
11.20MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
465.00MUSDFY2025 · Dec 31, 2025EPS (Basic)
10.37USDFY2025 · Dec 31, 2025EPS (Diluted)
10.26USDFY2025 · Dec 31, 2025Basic Shares Outstanding
247.60MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
247.60MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.57BUSDFY2025 · Dec 31, 2025Operating Cash Flow
3.25BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
207.20MUSDFY2025 · Dec 31, 2025Income Tax Paid
592.70MUSDFY2025 · Dec 31, 2025Interest Paid
453.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.57BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
676.90MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
153.20MUSDFY2025 · Dec 31, 2025Stock-based Compensation
123.50MUSDFY2025 · Dec 31, 2025Other Non-cash Items
338.50MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-178.90MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-37.80MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-397.10MUSDFY2025 · Dec 31, 2025Net Acquisitions
-1.21BUSDFY2025 · Dec 31, 2025Other Investing Activity
-57.40MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.27BUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.54BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.06BUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
523.90MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-1.66BUSDFY2025 · Dec 31, 2025Common Dividends Paid
-789.80MUSDFY2025 · Dec 31, 2025Other Financing Charges
-86.80MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.53BUSDFY2025 · Dec 31, 2025Shares Outstanding
246.64MSharesUpdated Jul 19, 2026Float Shares
228.55MSharesUpdated Jul 19, 2026Shares Short
7.90MSharesUpdated Jul 19, 2026Short Ratio
2.75daysvs all stocks
Short % of Shares Outstanding
3.20%vs all stocks
% Held by Insiders
6.28%vs all stocks
% Held by Institutions
82.76%vs all stocks
Total Cash (MRQ)
216.90MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.8850USDUpdated Jul 19, 2026Total Debt (MRQ)
14.60BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
3.30xvs Specialty Chemicals peers
Current Ratio (MRQ)
0.8630xvs Specialty Chemicals peers
Book Value per Share (MRQ)
18.07USDUpdated Jul 19, 2026Total Assets
25.90BUSDvs all stocks (USD)
Total Current Assets
6.01BUSDFY2025 · Dec 31, 2025Total Liabilities
21.30BUSDFY2025 · Dec 31, 2025Total Non-current Assets
19.89BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
14.38BUSDFY2025 · Dec 31, 2025Total Current Liabilities
6.92BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
207.20MUSDFY2025 · Dec 31, 2025Accounts Receivable
2.79BUSDFY2025 · Dec 31, 2025Inventory
2.32BUSDFY2025 · Dec 31, 2025Accounts Payable
2.35BUSDFY2025 · Dec 31, 2025Short-term Debt
2.03BUSDFY2025 · Dec 31, 2025Long-term Debt
10.91BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
2.58BUSDFY2025 · Dec 31, 2025Common Stock (Book)
83.10MUSDFY2025 · Dec 31, 2025Retained Earnings
1.03BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
4.60BUSDvs all stocks (USD)
Treasury Stock
84.30MUSDFY2025 · Dec 31, 202552-Week Low
289.86USDUpdated Jul 19, 202652-Week High
379.65USDUpdated Jul 19, 202652-Week Change
-2.92%vs all stocks
Beta
1.10xvs all stocks
50-Day MA
319.29USDUpdated Jul 19, 2026200-Day MA
333.02USDUpdated Jul 19, 2026Avg 10-Day Volume
1.82MSharesUpdated Jul 19, 2026Avg 30-Day Volume
2.55MSharesUpdated Jul 19, 2026Diluted EPS (TTM)
10.20USDUpdated Jul 19, 2026Other Income / Expense
11.70MUSDFY2025 · Dec 31, 20258 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Three Asset-Base Ratios Elevated
It gets more sales from its assets than its industry does, and a lot of profit from them too.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 49.1%, higher than 95% of its Specialty Chemicals peers (median 33%)Significant
Gross margin: 0.49Industry median: 0.33Industry P95: 0.49Peers compared: 20.00
Return on equity is 60.7%, higher than 95% of its Specialty Chemicals peers (median 8.1%)Significant
Return on equity: 0.61Industry median: 0.08Industry P95: 0.23Peers compared: 20.00
Return on assets is 9.4%, higher than 95% of its Specialty Chemicals peers (median 4.9%)Significant
Return on assets: 0.09Industry median: 0.05Industry P95: 0.09Peers compared: 20.00
Current ratio is 0.86×, lower than 95% of its Specialty Chemicals peers (median 1.74×)Significant
Current ratio: 0.86Industry median: 1.74Industry P5: 0.88Peers compared: 20.00
Debt-to-equity is 3.3×, higher than 95% of its Specialty Chemicals peers (median 0.47×)Significant
Debt-to-equity: 3.30Industry median: 0.47Industry P95: 1.57Peers compared: 20.00
Structural Tensions
Returns appear driven by leverageSignificant
Return on Equity: 0.61Debt-to-Equity: 3.30
Financial Health
Altman Z-Score 3.71: safe zoneNotable
Altman Z-Score: 3.71
High earnings qualityNotable
Earnings Quality Score: 0.73
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Market cap is $81.72B, higher than 95% of all stocks globallySignificant
Market cap (USD): 81,715,316,416Global P95: 25,614,208,870.135
Revenue is $23.94B, higher than 95% of all stocks globallySignificant
Revenue (USD): 23,935,500,288Global P95: 14,667,937,174.886
Levered free cash flow is $2.14B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 2,140,024,960Global P95: 1,123,592,359.78
Companies that share the same coordination system — how they create, deliver, or capture value.
HCA Healthcare Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Phillips 66
Tier 1ProductionThroughput-Bound ConversionFlowRule
3M Company
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Illinois Tool Works Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Semiconductor Manufacturing International Corporation
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Hyundai Motor Co.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hygon Information Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eoptolink Technology Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Emerson Electric Co.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Johnson Controls International plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Harmony Biosciences Holdings, Inc.
5 interpretationsROE, ROA, And Operating ROA ElevatedMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios Elevated
XPEL, Inc.
5 interpretationsROE, ROA, And Operating ROA ElevatedMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios Elevated
Fiem Industries Ltd.
5 interpretationsROE, ROA, And Operating ROA ElevatedMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Asset-Base Ratios Elevated
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.